SCHEMBL7799679

SCHEMBL7799679

CC1(C)CCC(C)(C)c2cc(C3(C)CSc4ccc(CO)cc43)ccc21

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP26B1 Q9NR63 8/20 0.42
CYP26A1 O43174 7/20 0.42
CYP3A4 P08684 1/20 0.42
RXRA P19793 11/20 0.40
RXRG P48443 4/20 0.40
RXRB P28702 4/20 0.40
RARB P10826 3/20 0.37
RARG P13631 3/20 0.37
RARA P10276 2/20 0.37
PPARG P37231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2095481 0.79 RXRA (0.57) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL7801896 0.79 RXRA (0.57) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL7793997 0.78 CYP26B1 (0.42) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL8092570 0.76 CYP3A4 (0.51) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL6733008 0.75 CYP26A1 (0.41) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL7799676 0.75 CYP26B1 (0.61) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL7799675 0.75 CYP26B1 (0.61) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL7935617 0.74 RARA (0.49) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL7794019 0.72 TTR (0.46) CYP26B1CYP26A1CYP3A4RXRARXRG
SCHEMBL7794024 0.72 TTR (0.46) CYP26B1CYP26A1CYP3A4RXRARXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882033-B1 BENZOFURAN-ACRYLIC ACID DERIVATIVES AND THEIR USE AS MODULATORS OF RXRS OR RARS RECEPTORS CT INTERNAT DE RECH S (FR) 2001-08-16 EP disclosed
US-6030952-A AS HUMAN AND VETERINARY MEDICINE, PARTICULARLY IN THE TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHTHALMOLOGIC CONDITIONS, AND IN COSMETIC COMPOSITIONS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIOUES GALDERMA (FR) 2000-02-29 US disclosed